Linde plc - Ordinary Shares (LIN)

On our desk, the narrative for Linde splits sharply into two camps. One side views LIN as an unreplicable 'fortress' asset with long-term, inflation-indexed contracts that easily justify a trailing P/E above 31x. The other side worries we are paying peak multiples for an industrial gas provider whose clean hydrogen expansion brings execution baggage. Sentiment sits right around 51% mildly defensive, giving us a cautious stance despite solid fundamentals.

Looking at the Q2 2026 numbers, the operational delivery is hard to fault. Sales hit $9,289 million—up 9% year-over-year—with adjusted diluted EPS coming in at $4.50. APAC sales outperformed with a 13% jump, while Americas and EMEA grew 7%. Operating cash flow for the first half reached $4,511 million against $2,780 million in capital expenditures. The balance sheet is spitting out cash, but at a 44.2x Price-to-FCF multiple, much of that operational excellence is already priced in.

When evaluating project pipelines in our research workflow, Linde’s $7.1 billion sale-of-gas backlog stands out as the core anchor. It effectively shields the business from broader cyclical downturns by embedding long-term demand from semiconductor fabrication, space-launch sectors, and chemical manufacturing. Analysts interviewing management need to press on how cost pass-through mechanisms are holding up against sticky inflation vectors in Europe and the Americas.

Watching the valuation metrics closely: forward P/E rests at 27.25x with a PEG ratio of 3.88x. EV-to-EBITDA stands at 18.18x alongside an EV-to-Revenue of 6.96x. While the underlying business is undeniably the world's largest industrial gas player following the Praxair merger, these multiples leave very little margin of safety if global manufacturing indices roll over in the second half of 2026.

From a risk management perspective, the options and short interest profile look exceptionally quiet. Institutional ownership sits heavily at 88.88%, while short interest is a modest 1.21% of the float. However, headline risks regarding EPS expectations can trigger sudden reactions—such as the recent Q2 report where reported EPS marginally missed consensus at the close, yet the stock still ticked 1.30% higher. We are maintaining a neutral risk posture until valuation compresses.